HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.

Abstract
Estrogen plays key regulatory roles in a variety of biological actions besides its classic function as a sex hormone. Recently, estrogen has been linked to neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD). Several lines of evidence support the notion that brain estrogen exerts neuroprotective effects against various types of neurotoxicity in different cellular and animal models. Despite some controversies, estrogen replacement therapy (ERT) at an early stage, especially when given prior to menopause, has been shown to reduce the risk of AD in postmenopausal women. In addition, multiple lines of evidence have proven the neuroprotective effects of estrogen, such as enhancing neurotrophin signaling and synaptic activities pertinent to memory functions and protecting neurons against oxidative injuries and beta-amyloid toxicity; the latter is widely accepted as the prime culprit known to trigger the pathogenesis of AD. Here we will summarize our findings that estrogen decreased generation and secretion of beta-amyloid peptides in cultured cells and primary neurons and that administration of estrogen in estrogen-deprived mice reversed the elevated levels of brain Abeta. We will also discuss the molecular and cellular mechanisms underlying estrogen's effects on Abeta metabolism, which is highlighted by our demonstration that estrogen increases intracellular trafficking of beta-amyloid precursor protein (betaAPP) and hence reduces maximal Abeta generation within the trans-Golgi network (TGN), a subcellular compartment in which APP is known to be cleaved by the secretase enzymes to generate Abeta.
AuthorsHuaxi Xu, Ruishan Wang, Yun-Wu Zhang, Xue Zhang
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 1089 Pg. 324-42 (Nov 2006) ISSN: 0077-8923 [Print] United States
PMID17261779 (Publication Type: Journal Article)
Chemical References
  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Estrogens
  • Peptide Fragments
  • Presenilin-1
  • Estradiol
Topics
  • Alzheimer Disease (etiology, metabolism)
  • Amyloid beta-Peptides (antagonists & inhibitors, metabolism)
  • Amyloid beta-Protein Precursor (genetics, metabolism)
  • Animals
  • Cells, Cultured
  • Estradiol (pharmacology)
  • Estrogens (metabolism, pharmacology)
  • Mice
  • Mice, Transgenic
  • Neurons (drug effects, metabolism)
  • Peptide Fragments (metabolism)
  • Presenilin-1 (genetics)
  • Protein Transport (drug effects)
  • trans-Golgi Network (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: